Posts

Just Slowly Going Down

The Bayesian Sinking, Mike Lynch, Darktrace, and the Cluster of Coincidences: Accident, Foul Play, or Something in Between? In the early hours of August 19, 2024, a violent and highly localized storm—described by witnesses as resembling a waterspout or mesocyclonic downburst—struck the luxury sailing superyacht Bayesian off the coast of Porticello, Sicily ( Sicily ). The 56-meter British-flagged vessel, owned by Angela Bacares (wife of tech entrepreneur Mike Lynch), capsized and sank in a matter of minutes while anchored just half a mile from shore. This was not a vessel caught far offshore in open-ocean chaos—it was positioned in relatively sheltered waters, which makes the speed and severity of the disaster all the more striking. Of the 22 people aboard—12 guests and 10 crew—7 lost their lives. The remaining 15 survived, many of them escaping under extreme conditions and ultimately clustering into a single overcrowded life raft in darkness and confusion. The victims included...
Post a Comment
Read more

Dirty Market and "Suicide"

The BBBY Saga: Meme Stocks, Market Chaos, and a Tragic Turning Point The story of Bed Bath & Beyond (BBBY) sits at the intersection of retail collapse, meme stock mania, and one of the more unsettling moments in recent market history. While there isn’t a single definitive Netflix-style documentary that captures the entire arc, the events surrounding BBBY—especially during its final years—have been widely covered in long-form YouTube documentaries, financial breakdowns, and retail investor discussions. The Meme Stock Surge Like GameStop before it, BBBY became a “meme stock”—a company whose price was driven less by fundamentals and more by retail investor enthusiasm, online communities, and short squeeze potential. Rapid price spikes fueled by retail traders Heavy short interest and speculation High-profile involvement from investors like Ryan Cohen For many, it felt like lightning might strike twice after Ga...
Post a Comment
Read more

What's Next?

Overnight Hold Opportunities - High % Potential with Defined Risk (3/25/2026) Overnight Hold Opportunities: High % Return Potential with Lower Downside Risk Date: March 25, 2026 (as of market close) • Prepared for educational / sharing purposes IMPORTANT DISCLAIMERS – READ CAREFULLY • This is NOT financial advice . The ideas below are derived from recent public commentary by selected trading-focused X accounts and basic technical/market data. • Overnight holds carry substantial risks including gap risk, after-hours news, and market volatility. • Entry/exit levels, % returns, and probabilities shown are estimated and hypothetical based on recent price action, structure, and catalysts. They are for illustration only and NOT guarantees. • Past performance does not predict future results. Stocks can move against you quickly. • Always do your own due diligence (DYOR), verify live prices/charts, and use proper risk management. Posi...
Post a Comment
Read more

IXHL Well Will You Look At That?

$IXHL Incannex Healthcare Inc. Detailed Trading & Company Notes As of March 25, 2026 (Post-Market) 1. 📊 Today's Price Action & Technical Snapshot Intraday Range: $2.80 – $3.45 Current / Last Trade: ~$3.00 – $3.30 (≈ +12–20% intraday depending on timing) Previous Close (Mar 24): ~$2.78 – $2.89 Volume: Significantly elevated (hundreds of thousands to ~1M shares) Market Cap: ~$33M – $47M (micro-cap) 52-Week Range: $2.40 – $49.80 (extreme volatility; reverse splits & dilution impact) Short-term Turnaround Attempt: Price is reacting positively to today’s AASM Foundation partnership news while bouncing from recent lows. What matters next: Watch for sustained volume and a hold above $3.50 for continuation. 2. 🧬 Company Overview Incannex Healthcare Inc. (NASDAQ: IXHL) is a clinical-stage biopharmaceutical company focused on developing innovative combination therapies, primarily involving cannabinoid and psychedelic compounds. Lead Progra...
Post a Comment
Read more

Been watching that ACON

ACON Stock: Breakout or Bull Trap? 📊 Ticker: ACON (Aclarion Inc.) ACON is finally making a move after sitting quiet for a long time — but the big question is: Is this a real breakout… or just another bull trap? 🔥 What’s Driving the Move Strong growth in Nociscan adoption (AI-based spine diagnostics) +69% year-over-year growth +114% Q4 growth Major clinical catalyst ahead: CLARITY trial (data expected in 2026) This is important because the move is being driven by real developments , not just hype. 📈 Why It Looks Like a Breakout (So Far) Massive spike in trading volume Strong upward price movement (40%–50%+) Shift in sentiment from bearish to bullish 👉 These are typical early signs of a potential breakout. ⚠️ Why It Could Still Be a Bull Trap Micro-cap stock (very low market cap) Extremely volatile price history Down significantly over the past year High risk of dilution or pullbacks 👉 These conditions often lead to s...
Post a Comment
Read more

MBRX What's your flex?

Wild Thought: A Creative Swing Trade Plan for MBRX (Moleculin Biotech) Wild Thought: What If? A Creative Swing Trade Idea for MBRX Just spitballing here… pure speculation and “what if” territory. I’m not a financial advisor, and this is not investment advice. Markets are wild, especially tiny biotech stocks. Important Disclaimer: This is for entertainment and educational purposes only. Trading stocks, especially micro-cap biotechs like MBRX, involves substantial risk of loss. You could lose some or all of your capital. Past performance is not indicative of future results. Always do your own due diligence, consult a licensed financial professional, and only risk money you can afford to lose. Prices and news referenced are as of late March 2026 (MBRX trading around $2.10 with a \~$10-11M market cap). Okay, buckle up. I’ve been watching Moleculin Biotech (MBRX) — a tiny biotech chasing a big swing in relapsed/refractory ac...
Post a Comment
Read more

Casino Time

🚀 Momentum Lotto Watchlist: AZTR + Others – TradingView Links (March 2026) IMPORTANT DISCLAIMER – READ FIRST This post is for informational and entertainment purposes ONLY. It is NOT financial advice, investment advice, a recommendation to buy/sell/hold any security, or personalized guidance of any kind. Trading stocks, especially low-priced/micro-cap/penny stocks like those listed here, involves EXTREME RISK and can result in the COMPLETE LOSS of your invested capital. Past price action, volume spikes, momentum, or analyst mentions do NOT guarantee future results. Markets are volatile and unpredictable. I am not a registered investment advisor, broker, or financial professional. Nothing here should be construed as such. Always Do Your Own Research (DYOR), consult a licensed financial advisor, and only risk money you can afford to lose entirely. Links are to public...
Post a Comment
Read more